201. MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism.
- Author
-
Quattrone A, Morelli M, Williams DR, Vescio B, Arabia G, Nigro S, Nicoletti G, Salsone M, Novellino F, Nisticò R, Pucci F, Chiriaco C, Pugliese P, Bosco D, and Caracciolo M
- Subjects
- Aged, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neurologic Examination, Observer Variation, Ocular Motility Disorders drug therapy, Parkinsonian Disorders drug therapy, Prognosis, Supranuclear Palsy, Progressive drug therapy, Brain diagnostic imaging, Magnetic Resonance Imaging, Ocular Motility Disorders diagnostic imaging, Parkinsonian Disorders diagnostic imaging, Supranuclear Palsy, Progressive diagnostic imaging
- Abstract
Objective: To identify a biomarker for predicting the appearance of vertical supranuclear gaze palsy (VSGP) in patients affected by progressive supranuclear palsy-parkinsonism (PSP-P)., Methods: Twenty-four patients with PSP-P were enrolled in the current study. Patients were clinically followed up every 6 months until the appearance of VSGP or the end of the follow-up (4 years). Participants underwent MRI at baseline and at the end of follow-up. Magnetic resonance parkinsonism index (MRPI), an imaging measure useful for diagnosing PSP, was calculated., Results: Twenty-one patients with PSP-P completed follow-up, and 3 patients dropped out. Eleven of 21 patients with PSP-P developed VSGP after a mean follow-up period of 28.5 months (range 6-48 months), while the remaining 10 patients with PSP-P did not develop VSGP during the 4-year follow-up period. At baseline, patients with PSP-P who later developed VSGP had MRPI values significantly higher than those of patients not developing VSGP without overlapping values between the 2 groups. MRPI showed a higher accuracy (100%) in predicting VSGP than vertical ocular slowness (accuracy 33.3%) or postural instability with or without vertical ocular slowness (accuracy 71.4% and 42.9%, respectively)., Conclusions: Our study demonstrates that MRPI accurately predicted, on an individual basis, the appearance of VSGP in patients with PSP-P, thus confirming clinical diagnosis in vivo., (© 2016 American Academy of Neurology.)
- Published
- 2016
- Full Text
- View/download PDF